Individuals diagnosed with genetic AAT deficiency carry S, Z, or other non-M variants of AAT [18]; their levels of circulating AAT are below normal, and unless treated, they endure non-smoking lung tissue degradation and are susceptible to excessive inflammatory conditions [19]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.